MALAT1 and neoplasm: An increased level of lncRNA in tumor cells increases their resistance to tamoxifen (lncRNA MALAT1 and CCAT2; miR-221, miR-222, miR,26a, miR-P29a, miR-29b) and trastuzumab (lncRNA, miR-16, and miR-155).